Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
INTRODUCTION: Observational studies using case-control designs have showed an increased risk of pneumonia associated with inhaled corticosteroid (ICS)-containing medications in patients with chronic obstructive pulmonary disease (COPD). New-user observational cohort designs may minimize biases assoc...
Main Authors: | Rachael L DiSantostefano, Tim Sampson, Hoa Van Le, David Hinds, Kourtney J Davis, Nawar Diar Bakerly |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4039434?pdf=render |
Similar Items
-
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
by: DiSantostefano RL, et al.
Published: (2014-05-01) -
The role of inhaled and/or nasal corticosteroids on the bronchodilator response
by: Ju Kyung Lee, et al.
Published: (2010-11-01) -
Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
by: Bishwakarma R, et al.
Published: (2017-01-01) -
Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
by: Cheng S, et al.
Published: (2017-07-01) -
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
by: Asche CV, et al.
Published: (2012-03-01)